Search clinical trials for: Machine learning algorithm

Total 10000 results

‹
1
2
...
71
72
73
74
75
76
77
...
199
200
›

Merck Sharp & Dohme LLC

Completed

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Anal Cancer | Genital Warts | Anal Intraepithelial Neoplasia
Sanaria Inc.
Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center; Military Infectious Diseases Research Program (MIDRP)

Completed

A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses

Malaria

United States
Sichuan University

Unknown

Personalized DC Vaccine for Lung Cancer (SKLB1608)

Carcinoma, Non-Small-Cell Lung

China
Health Sciences North Research Institute
NOAMA NORTHERN ONTARIO ACADEMIC MEDICINE ASSOCIATION

Unknown

Protection From Influenza: Determining the Impact of Prior Infection

Influenza

Canada
Postgraduate Institute of Medical Education and...

Unknown

Randomized Controlled Trial of Measles Vaccination Schedule

MEASLES DISEASE

India
GlaxoSmithKline

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus

Finland, Germany, Spain, Italy, France, Czech Republic
GlaxoSmithKline

Completed

A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine

Streptococcal Infections

Germany
GlaxoSmithKline

Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Germany
GlaxoSmithKline

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Infections, Meningococcal

Belgium
GlaxoSmithKline

Completed

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

Rotavirus Infections

South Africa
Fraunhofer, Center for Molecular Biotechnology
Walter Reed Army Institute of Research (WRAIR); Defense Advanced Research Projects...

Completed

Study of the Safety and Immunogenicity of H1N1 Vaccine

H1N1 Flu

United States
Beijing Center for Disease Control and Prevention

Completed

The Protection Effect of Speeda® Rabies Vaccine for Human Use

Rabies Vaccine Allergy

China
University of Wisconsin, Madison

Completed

Immunological Consequences of Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Fundación Pública Andaluza Progreso y Salud
Spanish Network for Research in Infectious Diseases

Completed

Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination (TraNsgripe)

Infection in Solid Organ Transplant Recipients

Spain
US Department of Veterans Affairs

Completed

Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment

Dual Diagnosis

United States
Merck Sharp & Dohme LLC

Terminated

Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).

Pediatric Gastroenteritis
VaxInnate Corporation

Completed

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49

Influenza

United States
Beijing Center for Disease Control and Prevention

Unknown

The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination

Varicella

China
Queen Sirikit National Institute of Child Health

Unknown

Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants

Immunogenicity | Reactogenicity

Thailand
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects

Influenza Disease

Italy
Novartis Vaccines

Completed

Purified Rabies Vaccine for Human Use (Chick-embryo Cell)

Rabies Post-exposure Prophylaxis

China
St. Jude Children's Research Hospital

Completed

Evaluation of the Safety of a Polyvalent Virus in Healthy Adults

HIV Infection | Human Immunodeficiency Virus

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

Pneumonic Plague | Preventive Therapy

United States
Tel-Aviv Sourasky Medical Center

Unknown

Influenza Vaccination in Patients With Scleroderma

Influenza Vaccine in Scleroderma

Israel
Novartis
Novartis Vaccines; Chiron s.r.l. Beijing Representative Office

Completed

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

Influenza

China
Mackay Memorial Hospital

Unknown

Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells

Carcinoma, Hepatocellular
VaxGen

Completed

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

Prevention of Anthrax Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

An HIV Vaccine Preparedness Study

HIV Infections

United States
National Research Centre, Egypt

Recruiting

Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)

COVID-19 | Vaccine Adverse Reaction | Vaccine Reaction

Egypt
CureVac
German Federal Ministry of Education and Research

Completed

A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Panama, Peru
Epicentre
Kenya Medical Research Institute

Completed

Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) (YEFE)

Yellow Fever

Uganda, Kenya
Respivert Ltd

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 Days

Asthma | Healthy Volunteers

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers

Japanese Encephalitis | Japanese Encephalitis Virus Disease

Korea, Republic of
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Sarcoma | Neuroblastoma

United States
Centers for Disease Control and Prevention
Emory University

Completed

Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine

Pneumococcal Infections

United States
Emory University
National Cancer Institute (NCI); Sanofi; National Institutes of Health (NIH)

Completed

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Plasma Cell Neoplasm

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older

Influenza Immunization

Puerto Rico, United States
Emergent BioSolutions

Completed

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

Influenza | Bird Flu

United States
Beijing Chaoyang District Centre for Disease Control...

Completed

Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.

Rabies
Hopital Foch

Terminated

Postoperative Sedation After Cardiac Surgery (SEDCAR)

Anesthesia | Surgery, Cardiac

France
Merck Sharp & Dohme LLC

Completed

A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)

HIV Infections | HIV-1
University of Maryland, Baltimore

Completed

Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine

Risk Reduction

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)

Influenza

Lithuania
Clinica Dermatologica Arbache ltda

Recruiting

MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine) (MMP)

Androgenic Alopecia

Brazil
University Hospital, Aachen

Completed

HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts (HOPE-ECD-DBD)

Liver Transplant | Hepatocellular Injury

Germany, Czechia
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Hematopoietic Cell Transplant Recipient | Cytomegaloviral Infection

United States
Pfizer

Active, not recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

Pneumococcal Disease

United States, Puerto Rico
Henry M. Jackson Foundation for the Advancement...
National Institute of Allergy and Infectious Diseases (NIAID); Uniformed Services... and other collaborators

Completed

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

HIV Infections | Streptococcus Pneumoniae

United States
University of Washington
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

Stage IV Breast Cancer | HER2/Neu Positive | HLA-A2 Positive Cells Present | Stage IV Ovarian Cancer

United States
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Jiangsu Province Center for...

Active, not recruiting

A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age

Varicella

China

‹
1
2
...
71
72
73
74
75
76
77
...
199
200
›

Subscribe